These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22854595)

  • 1. Stem cell transplantation into the intraventricular space via an Ommaya reservoir in a patient with amyotrophic lateral sclerosis.
    Baek W; Kim YS; Koh SH; Lim SW; Kim HY; Yi HJ; Kim H
    J Neurosurg Sci; 2012 Sep; 56(3):261-3. PubMed ID: 22854595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
    Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
    Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.
    Kim HY; Kim H; Oh KW; Oh SI; Koh SH; Baik W; Noh MY; Kim KS; Kim SH
    Stem Cells; 2014 Oct; 32(10):2724-31. PubMed ID: 24966156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial.
    Mazzini L; Ferrero I; Luparello V; Rustichelli D; Gunetti M; Mareschi K; Testa L; Stecco A; Tarletti R; Miglioretti M; Fava E; Nasuelli N; Cisari C; Massara M; Vercelli R; Oggioni GD; Carriero A; Cantello R; Monaco F; Fagioli F
    Exp Neurol; 2010 May; 223(1):229-37. PubMed ID: 19682989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice.
    Kim H; Kim HY; Choi MR; Hwang S; Nam KH; Kim HC; Han JS; Kim KS; Yoon HS; Kim SH
    Neurosci Lett; 2010 Jan; 468(3):190-4. PubMed ID: 19879334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
    Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
    JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial.
    Syková E; Rychmach P; Drahorádová I; Konrádová Š; Růžičková K; Voříšek I; Forostyak S; Homola A; Bojar M
    Cell Transplant; 2017 Apr; 26(4):647-658. PubMed ID: 27938483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis.
    Mazzini L; Mareschi K; Ferrero I; Vassallo E; Oliveri G; Boccaletti R; Testa L; Livigni S; Fagioli F
    Neurol Res; 2006 Jul; 28(5):523-6. PubMed ID: 16808883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-PIX is critical for transplanted mesenchymal stromal cell migration.
    Koh SH; Huh YM; Noh MY; Kim HY; Kim KS; Lee ES; Ko HJ; Cho GW; Yoo AR; Song HT; Hwang S; Lee K; Haam S; Frank JA; Suh JS; Kim SH
    Stem Cells Dev; 2012 Jul; 21(11):1989-99. PubMed ID: 22087847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.
    Chan-Il C; Young-Don L; Heejaung K; Kim SH; Suh-Kim H; Kim SS
    Cell Transplant; 2013; 22(5):855-70. PubMed ID: 22472631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of cerebrospinal fluid of amyotrophic lateral sclerosis patients in the presence of autologous bone marrow derived mesenchymal stem cells.
    Reis ALG; Maximino JR; Lage LAPC; Gomes HR; Pereira J; Brofman PRS; Senegaglia AC; Rebelatto CLK; Daga DR; Paiva WS; Chadi G
    Stem Cell Res Ther; 2024 Sep; 15(1):301. PubMed ID: 39278909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of mesenchymal stem cells in ALS.
    Mazzini L; Vercelli A; Ferrero I; Boido M; Cantello R; Fagioli F
    Prog Brain Res; 2012; 201():333-59. PubMed ID: 23186722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis.
    Boucherie C; Schäfer S; Lavand'homme P; Maloteaux JM; Hermans E
    J Neurosci Res; 2009 Jul; 87(9):2034-46. PubMed ID: 19267424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell treatment in Amyotrophic Lateral Sclerosis.
    Mazzini L; Mareschi K; Ferrero I; Vassallo E; Oliveri G; Nasuelli N; Oggioni GD; Testa L; Fagioli F
    J Neurol Sci; 2008 Feb; 265(1-2):78-83. PubMed ID: 17582439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis.
    Vercelli A; Mereuta OM; Garbossa D; Muraca G; Mareschi K; Rustichelli D; Ferrero I; Mazzini L; Madon E; Fagioli F
    Neurobiol Dis; 2008 Sep; 31(3):395-405. PubMed ID: 18586098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoport with a non-collapsible chamber as a replacement for an Ommaya reservoir in the treatment of leptomeningeal carcinomatosis.
    Gwak HS; Lee CH; Yang HS; Joo J; Shin SH; Yoo H; Lee JS; Lee SH
    Acta Neurochir (Wien); 2011 Oct; 153(10):1971-8; discussion 1978. PubMed ID: 21796363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel cell transplantation protocol and its application to an ALS mouse model.
    Morita E; Watanabe Y; Ishimoto M; Nakano T; Kitayama M; Yasui K; Fukada Y; Doi K; Karunaratne A; Murrell WG; Sutharsan R; Mackay-Sim A; Hata Y; Nakashima K
    Exp Neurol; 2008 Oct; 213(2):431-8. PubMed ID: 18691571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraventricular Transplantation of Autologous Bone Marrow Mesenchymal Stem Cells via Ommaya Reservoir in Persistent Vegetative State Patients after Haemorrhagic Stroke: Report of Two Cases & Review of the Literature.
    Fauzi AA; Suroto NS; Bajamal AH; Machfoed MH
    J Stem Cells Regen Med; 2016; 12(2):100-104. PubMed ID: 28096634
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.
    Karussis D; Karageorgiou C; Vaknin-Dembinsky A; Gowda-Kurkalli B; Gomori JM; Kassis I; Bulte JW; Petrou P; Ben-Hur T; Abramsky O; Slavin S
    Arch Neurol; 2010 Oct; 67(10):1187-94. PubMed ID: 20937945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.